mRNA Vaccine Nanoplatforms and Innate Immunity
Viruses · 14.01.2024 · 16 (1) · 120
DOI: 10.3390/v16010120 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 14.01.2024. Verfasst von Lai Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA. Hauptthemen laut MEDLINE: mRNA Vaccines, Pandemics. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, US National Institutes of Health (NIH).
Abstract (Originalsprache)
mRNA-based vaccine technology has been significantly developed and enhanced, particularly highlighted by the authorization of mRNA vaccines for addressing the COVID-19 pandemic. Various biomaterials are developed in nano-scales and applied as mRNA vaccine delivery platforms. However, how these mRNA nanoplatforms influence immune responses has not been thoroughly studied. Hence, we have reviewed the current understanding of various mRNA vaccine platforms. We discussed the possible pathways through which these platforms moderate the host’s innate immunity and contribute to the development of adaptive immunity. We shed light on their development in reducing biotoxicity and enhancing antigen delivery efficiency. Beyond the built-in adjuvanticity of mRNA vaccines, we propose that supplementary adjuvants may be required to fine-tune and precisely control innate immunity and subsequent adaptive immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.
ORCID-Profile: Chunhong Dong, Bao-Zhong Wang
Förderung
- NIAID NIH HHS
- NIH HHS
- US National Institutes of Health (NIH)
Zitieren
APA
Wei, L., Dong, C., Zhu, W., & Wang, B. Z. (2024). mRNA Vaccine Nanoplatforms and Innate Immunity. Viruses, 16(1), 120. https://doi.org/10.3390/v16010120
Vancouver
Wei L, Dong C, Zhu W, Wang BZ. mRNA Vaccine Nanoplatforms and Innate Immunity. Viruses. 2024;16(1):120. doi:10.3390/v16010120
BibTeX
@article{Wei2024,
author = {Wei, Lai and Dong, Chunhong and Zhu, Wandi and Wang, Bao-Zhong},
title = {mRNA Vaccine Nanoplatforms and Innate Immunity},
journal = {Viruses},
year = {2024},
volume = {16},
number = {1},
pages = {120},
doi = {10.3390/v16010120}
}
EUVIMED